Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis

Molecular Cell
Y NominéGilles Travé

Abstract

Oncoprotein E6 is essential for oncogenesis induced by human papillomaviruses (HPVs). The solution structure of HPV16-E6 C-terminal domain reveals a zinc binding fold. A model of full-length E6 is proposed and analyzed in the context of HPV evolution. E6 appears as a chameleon protein combining a conserved structural scaffold with highly variable surfaces participating in generic or specialized HPV functions. We investigated surface residues involved in two specialized activities of high-risk genital HPV E6: p53 tumor suppressor degradation and nucleic acid binding. Screening of E6 surface mutants identified an in vivo p53 degradation-defective mutant that fails to recruit p53 to ubiquitin ligase E6AP and restores high p53 levels in cervical carcinoma cells by competing with endogeneous E6. We also mapped the nucleic acid binding surface of E6, the positive potential of which correlates with genital oncogenicity. E6 structure-function analysis provides new clues for understanding and counteracting the complex pathways of HPV-mediated pathogenesis.

References

Mar 1, 1990·Journal of Molecular Graphics·G Vriend
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E BonnefoyJ Rouviere-Yaniv
Feb 1, 1996·Journal of Molecular Graphics·R KoradiK Wüthrich
Jun 22, 1999·Oncogene·F De GraeveB Chatton
Sep 26, 2001·Protein Expression and Purification·Y NominéG Travé
Jan 5, 2002·Cellular and Molecular Life Sciences : CMLS·G Dell, K Gaston
Jan 29, 2003·Journal of Virology·Lucia G Le Roux, Junona Moroianu
Feb 5, 2003·Journal of Magnetic Resonance·Charles D SchwietersG Marius Clore
Jul 18, 2003·The Journal of General Virology·Murielle MassonEtienne Weiss
May 29, 2004·The Journal of General Virology·Deborah StewartGreg Matlashewski
Sep 28, 2004·The Journal of General Virology·Helena Sterlinko Grm, Lawrence Banks
Sep 17, 2005·Cancer Research·Sara J S SimonsonPaul F Lambert

❮ Previous
Next ❯

Citations

Dec 23, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Susanne DymallaKarin Hoppe-Seyler
Dec 25, 2012·Archives of Gynecology and Obstetrics·Qiong CaiAiping Dian
Jan 4, 2008·Archives of Virology·Sandy S Tungteakkhun, Penelope J Duerksen-Hughes
Jun 20, 2008·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Rong LiuLibo Zhao
Feb 16, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Quan MeiHui Wang
Apr 13, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kakoli BoseJames D Baleja
Jul 18, 2008·Journal of Virology·Sandy S TungteakkhunPenelope J Duerksen-Hughes
Oct 19, 2007·Journal of Virology·Pedja SekaricElliot J Androphy
Nov 26, 2008·BMC Biochemistry·Sylvie Beaudenon, Jon M Huibregtse
Jun 10, 2008·Virology Journal·Laurent MaillyFrançois Deryckere
Dec 15, 2010·International Journal of Biological Sciences·Zhi-Ming Zheng
Feb 4, 2014·BioMed Research International·Yazmín Gómez-GómezPatricio Gariglio
Nov 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Indrani PaulErnest L Maynard
Jun 4, 2015·Emerging Microbes & Infections·Masahiko Ajiro, Zhi-Ming Zheng
Jul 30, 2008·Virus Genes·Daniela Marreco CerqueiraCláudia Renata Fernandes Martins
Aug 5, 2015·Journal of Clinical Medicine·Hun Soon JungYoung Kee Shin
Jul 26, 2014·Cancers·Tamara A BelyaevaNicola J Stonehouse
Feb 6, 2016·BMC Evolutionary Biology·Beatriz Mengual-ChuliáIgnacio G Bravo
Dec 5, 2012·Vaccine·Peter L SternMark H Einstein
Dec 5, 2012·Vaccine·John DoorbarMargaret A Stanley
Nov 21, 2012·Microbial Pathogenesis·Chai Ling Pang, Françoise Thierry
Jun 5, 2012·Current Opinion in Virology·Margaret E McLaughlin-DrubinKarl Munger
May 17, 2012·Otolaryngologic Clinics of North America·Naren N VenkatesanMichael P Underbrink
Jul 23, 2011·Protein Expression and Purification·Abdellahi Ould M'hamed Ould SidiKatia Zanier
May 28, 2011·Biochimica Et Biophysica Acta·Zhi-Ming Zheng, Xiaohong Wang
Jan 29, 2016·Expert Review of Proteomics·Krystal K Lum, Ileana M Cristea
May 4, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maarten NiemantsverdrietRobert P Coppes
Feb 27, 2009·Journal of Molecular Biology·Yuqi LiuJames D Baleja
Jan 20, 2016·BioMed Research International·Rodrigo Pinheiro AraldiRita de Cassia Stocco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis